USPTO serial 79439488
PERFUSOL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- MAHMOUDI, MARIAM AZIZ
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with PERFUSOL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Milena S. Mishev
Milena S. Mishev Secant IP, P.L.L.C.55 S Commercial Street, Suite B14Manchester, NH 03101United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical and pharmaceutical solutions used in mechanical perfusion for storing, preserving, warehousing, and stabilizing organs; medical and pharmaceutical solutions for maintaining and extending the functionality of organs; medical and pharmaceutical solutions for mechanical organ perfusion during transport to the recipient; pharmaceutical preparations for medical purposes for use in the treatment of organs for transplantation; medical preparations used in mechanical perfusion for storing, preserving, warehousing, and stabilizing organs and maintaining and extending the functionality of organs; pharmaceutical preparations used in mechanical perfusion for storing, preserving, warehousing, and stabilizing organs and maintaining and extending the functionality of organs; medical and pharmaceutical preparations for activating cell functions, for storing, preserving, warehousing, and stabilizing organs and maintaining and extending the functionality of organs and for tissue generation; medical and pharmaceutical preparations and substances, namely, capillary stabilising agents for medical purposes, solutions for organ perfusion in mechanical perfusion and solutions for mechanical organ perfusion during transport to the recipient | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 8, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 8, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 2, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 12, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 11, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 11, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 11, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 21, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 1, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 1, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 24, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 23, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 16, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 30, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 30, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 18, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |